06 Jul 2017

Anti-malaria tablets: one brand of atovaquone/proguanil to be available to purchase without prescription

A brand of anti-malaria tablet, previously available by prescription only, will shortly be available from pharmacies as an Over the Counter (OTC) medicine Anti-malaria tablets: one brand of atovaquone/proguanil to be available to purchase without prescription

Atovaquone/proguanil, a combination tablet that can be taken to prevent malaria, is currently available in branded and non-branded forms.

Following a public consultation process [1], the Medicines and Healthcare products Regulatory Agency has announced one named brand of atovaquone/proguanil as approved as an Over the Counter (OTC) medicine. This medicine will shortly be available through pharmacies without prescription and will be available to adults aged over 18, weighing more than 40kg, travelling to areas affected by malaria and where the malaria parasite is not resistant to the product ingredients [2].

Health professionals are reminded that pre-travel risk assessment is essential to tailor advice for an individual, including advice about malaria risk and options for medicine to prevent malaria.

Country requirements for an International Certificate of Vaccination or Prophylaxis (ICVP): key changes for 2018

TravelHealthPro has been updated to reflect updates to yellow fever recommendations and certificate requirements Read more

Imported malaria cases in the United Kingdom in 2017

Public Health England publishes 2017 imported UK malaria cases Read more

Public Health England post-exposure rabies treatment guidance published

Updated guidelines on rabies post-exposure treatment Read more

PHE update Yellow fever - Chapter 35 of the Green Book

Public Health England publishes update to Immunisation against infectious disease (Green Book) Yellow fever chapter online on 14 June 2018 Read more
Back to Top

VIEW FULL INDEX